Literature DB >> 17135164

Devil's Claw (Harpagophytum procumbens DC): an evidence-based systematic review by the Natural Standard Research Collaboration.

Thomas Brendler1, Joerg Gruenwald, Catherine Ulbricht, Ethan Basch.   

Abstract

An evidence-based systematic review including written and statistical analysis of scientific literature, expert opinion, folkloric precedent, history, pharmacology, kinetics/dynamics, interaction, adverse effects, toxicology, and dosing.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17135164

Source DB:  PubMed          Journal:  J Herb Pharmacother        ISSN： 1522-8940


  5 in total

1.  Maturation of the adrenal medulla--IV. Effects of morphine.

Authors:  T R Anderson; T A Slotkin
Journal:  Biochem Pharmacol       Date:  1975-08-15       Impact factor: 5.858

Review 2.  Herb-drug interactions: an overview of systematic reviews.

Authors:  Paul Posadzki; Leala Watson; Edzard Ernst
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 3.  Anti-coagulant activity of plants: mini review.

Authors:  Muhammad Akram; Abid Rashid
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

4.  Devil's Claw to suppress appetite--ghrelin receptor modulation potential of a Harpagophytum procumbens root extract.

Authors:  Cristina Torres-Fuentes; Wessel F Theeuwes; Michael K McMullen; Anna K McMullen; Timothy G Dinan; John F Cryan; Harriët Schellekens
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

5.  In vitro antioxidant activity of crude extracts of Harpagophytum zeyheri and their anti-inflammatory and cytotoxicity activity compared with diclofenac.

Authors:  Sibonokuhle F Ncube; Lyndy J McGaw; Emmanuel Mfotie Njoya; Hilton G T Ndagurwa; Peter J Mundy; Samson Sibanda
Journal:  BMC Complement Med Ther       Date:  2021-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.